CCR2 variants are associated with a protective effect against the progression of HIV infection, with a 58% lower risk of developing AIDS in the first 4 years after seroconversion and a 19% lower risk during the next 4 years of observation after seroconversion [8]. Here, CCR2 is linked to AIDS.